Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.06 (-3.85%)
Close on Nov 13, 2026Market cap $39.42MP/E –Yield –
Elicio Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Elicio Therapeutics's total assets was $39.60M at Sep 30, 2026. For fiscal 2025 it was $25.86M, down 8.2% from the year before. The highest annual figure on record is $96.51M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.86M | -8.2% |
| FY2024 | Dec 31, 2024 | $28.18M | +3.8% |
| FY2023 | Dec 31, 2023 | $27.15M | +19.8% |
| FY2022 | Dec 31, 2022 | $22.66M | -76.5% |
| FY2021 | Dec 31, 2021 | $96.51M | +103.8% |
| FY2020 | Dec 31, 2020 | $47.35M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $39.60M | +40.0% |
| Q2 FY2026 | Jun 30, 2026 | $31.33M | +6.1% |
| Q1 FY2026 | Mar 31, 2026 | $22.69M | -19.4% |
| Q4 FY2025 | Dec 31, 2025 | $25.86M | -8.2% |
| Q3 FY2025 | Sep 30, 2025 | $28.28M | -26.3% |
| Q2 FY2025 | Jun 30, 2025 | $29.53M | +87.5% |
| Q1 FY2025 | Mar 31, 2025 | $28.14M | +15.0% |
| Q4 FY2024 | Dec 31, 2024 | $28.18M | +3.8% |
| Q3 FY2024 | Sep 30, 2024 | $38.39M | +23.9% |
| Q2 FY2024 | Jun 30, 2024 | $15.75M | -58.1% |
| Q1 FY2024 | Mar 31, 2024 | $24.48M | -41.4% |
| Q4 FY2023 | Dec 31, 2023 | $27.15M | +19.8% |
| Q3 FY2023 | Sep 30, 2023 | $30.99M | -49.5% |
| Q2 FY2023 | Jun 30, 2023 | $37.62M | -46.9% |
| Q1 FY2023 | Mar 31, 2023 | $41.77M | -48.6% |
| Q4 FY2022 | Dec 31, 2022 | $22.66M | -76.5% |
| Q3 FY2022 | Sep 30, 2022 | $61.32M | -44.2% |
| Q2 FY2022 | Jun 30, 2022 | $70.81M | -43.5% |
| Q1 FY2022 | Mar 31, 2022 | $81.26M | -41.6% |
| Q4 FY2021 | Dec 31, 2021 | $96.51M | +103.8% |
| Q3 FY2021 | Sep 30, 2021 | $109.94M | – |
| Q2 FY2021 | Jun 30, 2021 | $125.36M | – |
| Q1 FY2021 | Mar 31, 2021 | $139.20M | – |
| Q4 FY2020 | Dec 31, 2020 | $47.35M | – |
See a number that looks wrong?